Attention Student & Post-doc members:
The 2022 Antibody Research Competition
is now open!
The Antibody Society sponsors competitions each year to recognize and encourage the research activities of promising student/postdoctoral fellows.
We invite you to submit a summary of your work on a topic related to antibody research. While such summaries are traditionally presented as posters, feel free to be creative and present the content in other formats, such as video.
Relevant topics include, but are not limited to:
- Antibody engineering or design
- Antibody therapeutics
- Fc effector functions
- Bispecific antibodies
- Antibody-drug conjugates
- Adaptive immune receptor repertoires
The winning antibody research will be featured on The Antibody Society’s website and winners will receive a $400 USD cash prize.
Two winners (1 student, 1 post-doc) will be selected by our panel of judges based on the originality, creativity, scientific merit, and clarity of their research and its presentation.
Send your entry to membership@antibodysociety.org. The first 30 submissions will be considered for the competition. Please include your contact details and whether you are a student or post-doc in your email.
Submission deadline: July 15, 2022
Entry is limited to The Antibody Society student and post-doc members.
Not a member? Register for your free membership!
Please note that all entrants must abide by the competition rules:
The Antibody Research Competition is open only to Society student and postdoctoral members (membership is free).
Submissions must focus on the original work of the entrant, but may include research conducted in collaboration with other contributors, such as advisors, with attribution and their express permission.
Submissions should consist of original work that is not yet accepted for publication. If the work builds on previously published work, the submission should focus on the new findings, with the previously published work cited for context.
Entries should be submitted to membership@antibodysociety.org.
By entering you grant permission for the work to be published on the Society’s website if you are selected as a winner.
Past winners:
2021 Antibody Engineering & Therapeutics Europe best poster winners:
Ms. Suchada Niamsuphap (Australian Institute for Bioengineering and Nanotechnology)
Poster title: Development of antibody delivery systems against intracellular targets
Dr. Vaishali Verma (University of Delhi South Campus)
Poster title: ImPACT: Immunization-free Phage-based Antibody Cloning Technology
2020 Antibody Engineering & Therapeutics Europe best poster winners:
Ms. Monica Fernandez-Quintero (University of Innsbruck)
Poster title: Antibodies exhibit multiple paratope states that can differ in VH-VL domain orientations;
and
Dr. Christian Fercher (University of Queensland)
Poster title: Development of Reagentless Fluorescence Immunosensors for Continuous Analyte Monitoring
2020 Antibody Engineering & Therapeutics best poster winners:
Felix Goerdeler, Max Planck Institute of Colloids and Interfaces, Germany
Poster title: Fighting protozoan parasites using carbohydrate-binding nanobodies
Dr. Nicolas Bery, Cancer Research Centre of Toulouse, France
Poster title: Discovery of a potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
2019 Antibody Engineering & Therapeutics Europe best poster winners:
Dr. Roberta Lotti, University of Modena and Reggio Emilia
Poster title: Neutralization of soluble Fas Ligand (sFasL) blocks blister formation without immunosuppression in pemphigus: development of PC111, a new monoclonal anti-FasL antibody.
Roberta Lotti with poster
Amiram Sananes, Ben-Gurion University
Poster title: A selective, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy and imaging, developed by combinatorial engineering.
Amiram Sananes with poster and award
2019 Antibody Engineering & Therapeutics best poster winners:
Timothy Czajka, University of New York at Albany.
Poster title: RIP-Off: An Intrabody-based Strategy to Neutralize Ricin and other Ribosome-Inactivating Protein (RIP) Toxins.
Dr. Kamal Joshi, Genentech.
Poster title: Toward Deeper Understanding of Bispecific Antibodies
-
- Timothy Czajka
-
- Dr. Kamal Joshi
The winners’ award ceremony comments:
Timothy Czajka:
“Thank you again to the Antibody Society for this recognition and opportunity to speak here. This is my third time attending the Antibody Engineering and Therapeutics conference and each time I’ve learned more than I could possibly remember and return to the lab with a huge surge of excitement and several new ideas that I’d like to apply to my own project. I’m honored to be able to present my own research this year alongside so many fascinating talks and to be able to engage with many different experts in the field. I would also like to thank my adviser, Nicholas Mantis, and Anne Messer for their help with my research and encouragement to attend and apply for this award.”
Kamal Joshi:
“It is an honor to receive this award. I would like to thank the judges for conferring this recognition on my work. I would also like to thank the Antibody Society, of course for funding my trip here but more importantly for organizing these fantastic meetings and providing a solid platform for the exchange of the latest information on antibody research and development benefiting all including early stage career scientists like me. It’s a real treat coming back to this meeting every time. Not only do I learn what is ongoing in the field, this meeting also provides me the opportunity to network with fellow scientists and facilitate connections. So again, thank you to the Antibody Society for this award. Thank you all.”
